Jin Wei Kou
Director of Finance/CFO at Universal Bespoke Condiment Co., Ltd.
Jin Wei Kou active positions
Companies | Position | Start | End |
---|---|---|---|
Universal Bespoke Condiment Co., Ltd.
Universal Bespoke Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Universal Bespoke Condiment Co., Ltd. is an investment holding company. It is involved in research and development, manufacturing and sale of compound condiment and extracts products. The company was founded on August 23, 2016 and is headquartered in Hong Kong. | Director of Finance/CFO | 20/07/2017 | - |
Career history of Jin Wei Kou
Former positions of Jin Wei Kou
Companies | Position | Start | End |
---|---|---|---|
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Director of Finance/CFO | 20/07/2017 | 31/12/2017 |
Marcum Asia CPAs LLP
Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Chief Executive Officer | 31/12/2007 | 31/12/2015 |
Deloitte Touche Tohmatsu CPA Ltd.
Deloitte Touche Tohmatsu CPA Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu CPA Ltd. is a Chinese company that provides accounting, tax, audit, and assurance services. The company is based in Shanghai, China. The company was founded in 1993. | Corporate Officer/Principal | 30/06/2005 | 31/03/2008 |
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Comptroller/Controller/Auditor | 15/09/2019 | - |
Director of Finance/CFO | 15/09/2019 | - |
Training of Jin Wei Kou
Peking University | Undergraduate Degree |
Statistics
International
China | 4 |
Cayman Islands | 3 |
United States | 2 |
Operational
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectoral
Consumer Non-Durables | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Universal Bespoke Condiment Co., Ltd.
Universal Bespoke Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Universal Bespoke Condiment Co., Ltd. is an investment holding company. It is involved in research and development, manufacturing and sale of compound condiment and extracts products. The company was founded on August 23, 2016 and is headquartered in Hong Kong. | Consumer Non-Durables |
Deloitte Touche Tohmatsu CPA Ltd.
Deloitte Touche Tohmatsu CPA Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu CPA Ltd. is a Chinese company that provides accounting, tax, audit, and assurance services. The company is based in Shanghai, China. The company was founded in 1993. | Commercial Services |
Marcum Asia CPAs LLP
Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Consumer Non-Durables |
Xynomic Pharmaceuticals Holdings, Inc.
Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Jin Wei Kou
- Experience